Jonathan White, CRNA | |
2809 Denny Ave, Pascagoula, MS 39581-5301 | |
(228) 809-5000 | |
Not Available |
Full Name | Jonathan White |
---|---|
Gender | Male |
Speciality | Certified Registered Nurse Anesthetist (crna) |
Experience | 12 Years |
Location | 2809 Denny Ave, Pascagoula, Mississippi |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1073865762 | NPI | - | NPPES |
03953595 | Medicaid | MS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
367500000X | Nurse Anesthetist, Certified Registered | 901408 (Mississippi) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Singing River Health System | Pascagoula, MS | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Hogan Surgical Center Pa | 4880791490 | 7 |
Jackson County Anesthesia | 9931292729 | 40 |
Singing River Health System | 3870405194 | 156 |
News Archive
Emergent BioSolutions Inc. announced today that it has signed a contract, valued at up to $186.6 million, with the Biomedical Advanced Research and Development Authority of the Department of Health and Human Services, for the development of a recombinant protective antigen anthrax vaccine.
The Nursing Program at the Akron Campus of Bryant & Stratton College has received initial accreditation from the Accreditation Commission for Education in Nursing (ACEN) for the maximum period of five years.
A University of Illinois at Chicago researcher will test whether brain stimulation combined with gait training can improve patients' ability to walk after a stroke, under a $1.5 million grant from the National Institute of Child Health and Human Development.
A sub-study of the Outcome Reduction with an Initial Glargine Intervention (ORIGIN) trial, designed to investigate the effect of insulin glargine and omega-3 fatty acids on atherosclerosis progression, has found that, compared to standard care, only insulin glargine (a long-acting insulin) had a "modest" statistically non-significant reducing effect on the primary outcome of rate of change in maximum carotid intima media thickness (CIMT) at 12 carotid sites.
Prometheus Research LLC has formed the Prometheus Solutions group to help customers develop data-driven solutions, including dashboards and reports. The group will draw on expertise developed by the company in its ten years of building custom biomedical data management applications.
› Verified 3 days ago
Entity Name | Singing River Health System |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1083893937 PECOS PAC ID: 3870405194 Enrollment ID: O20031104000435 |
News Archive
Emergent BioSolutions Inc. announced today that it has signed a contract, valued at up to $186.6 million, with the Biomedical Advanced Research and Development Authority of the Department of Health and Human Services, for the development of a recombinant protective antigen anthrax vaccine.
The Nursing Program at the Akron Campus of Bryant & Stratton College has received initial accreditation from the Accreditation Commission for Education in Nursing (ACEN) for the maximum period of five years.
A University of Illinois at Chicago researcher will test whether brain stimulation combined with gait training can improve patients' ability to walk after a stroke, under a $1.5 million grant from the National Institute of Child Health and Human Development.
A sub-study of the Outcome Reduction with an Initial Glargine Intervention (ORIGIN) trial, designed to investigate the effect of insulin glargine and omega-3 fatty acids on atherosclerosis progression, has found that, compared to standard care, only insulin glargine (a long-acting insulin) had a "modest" statistically non-significant reducing effect on the primary outcome of rate of change in maximum carotid intima media thickness (CIMT) at 12 carotid sites.
Prometheus Research LLC has formed the Prometheus Solutions group to help customers develop data-driven solutions, including dashboards and reports. The group will draw on expertise developed by the company in its ten years of building custom biomedical data management applications.
› Verified 3 days ago
Entity Name | Hogan Surgical Center Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1104829597 PECOS PAC ID: 4880791490 Enrollment ID: O20070618000014 |
News Archive
Emergent BioSolutions Inc. announced today that it has signed a contract, valued at up to $186.6 million, with the Biomedical Advanced Research and Development Authority of the Department of Health and Human Services, for the development of a recombinant protective antigen anthrax vaccine.
The Nursing Program at the Akron Campus of Bryant & Stratton College has received initial accreditation from the Accreditation Commission for Education in Nursing (ACEN) for the maximum period of five years.
A University of Illinois at Chicago researcher will test whether brain stimulation combined with gait training can improve patients' ability to walk after a stroke, under a $1.5 million grant from the National Institute of Child Health and Human Development.
A sub-study of the Outcome Reduction with an Initial Glargine Intervention (ORIGIN) trial, designed to investigate the effect of insulin glargine and omega-3 fatty acids on atherosclerosis progression, has found that, compared to standard care, only insulin glargine (a long-acting insulin) had a "modest" statistically non-significant reducing effect on the primary outcome of rate of change in maximum carotid intima media thickness (CIMT) at 12 carotid sites.
Prometheus Research LLC has formed the Prometheus Solutions group to help customers develop data-driven solutions, including dashboards and reports. The group will draw on expertise developed by the company in its ten years of building custom biomedical data management applications.
› Verified 3 days ago
Entity Name | Jackson County Anesthesia |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1922159219 PECOS PAC ID: 9931292729 Enrollment ID: O20070913000898 |
News Archive
Emergent BioSolutions Inc. announced today that it has signed a contract, valued at up to $186.6 million, with the Biomedical Advanced Research and Development Authority of the Department of Health and Human Services, for the development of a recombinant protective antigen anthrax vaccine.
The Nursing Program at the Akron Campus of Bryant & Stratton College has received initial accreditation from the Accreditation Commission for Education in Nursing (ACEN) for the maximum period of five years.
A University of Illinois at Chicago researcher will test whether brain stimulation combined with gait training can improve patients' ability to walk after a stroke, under a $1.5 million grant from the National Institute of Child Health and Human Development.
A sub-study of the Outcome Reduction with an Initial Glargine Intervention (ORIGIN) trial, designed to investigate the effect of insulin glargine and omega-3 fatty acids on atherosclerosis progression, has found that, compared to standard care, only insulin glargine (a long-acting insulin) had a "modest" statistically non-significant reducing effect on the primary outcome of rate of change in maximum carotid intima media thickness (CIMT) at 12 carotid sites.
Prometheus Research LLC has formed the Prometheus Solutions group to help customers develop data-driven solutions, including dashboards and reports. The group will draw on expertise developed by the company in its ten years of building custom biomedical data management applications.
› Verified 3 days ago
Entity Name | Singing River Gulfport |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1861010159 PECOS PAC ID: 5294154829 Enrollment ID: O20201001001497 |
News Archive
Emergent BioSolutions Inc. announced today that it has signed a contract, valued at up to $186.6 million, with the Biomedical Advanced Research and Development Authority of the Department of Health and Human Services, for the development of a recombinant protective antigen anthrax vaccine.
The Nursing Program at the Akron Campus of Bryant & Stratton College has received initial accreditation from the Accreditation Commission for Education in Nursing (ACEN) for the maximum period of five years.
A University of Illinois at Chicago researcher will test whether brain stimulation combined with gait training can improve patients' ability to walk after a stroke, under a $1.5 million grant from the National Institute of Child Health and Human Development.
A sub-study of the Outcome Reduction with an Initial Glargine Intervention (ORIGIN) trial, designed to investigate the effect of insulin glargine and omega-3 fatty acids on atherosclerosis progression, has found that, compared to standard care, only insulin glargine (a long-acting insulin) had a "modest" statistically non-significant reducing effect on the primary outcome of rate of change in maximum carotid intima media thickness (CIMT) at 12 carotid sites.
Prometheus Research LLC has formed the Prometheus Solutions group to help customers develop data-driven solutions, including dashboards and reports. The group will draw on expertise developed by the company in its ten years of building custom biomedical data management applications.
› Verified 3 days ago
Entity Name | Singing River Health System |
---|---|
Entity Type | Part B Supplier - Hospital Department(s) |
Entity Identifiers | NPI Number: 1740918937 PECOS PAC ID: 3870405194 Enrollment ID: O20221202000423 |
News Archive
Emergent BioSolutions Inc. announced today that it has signed a contract, valued at up to $186.6 million, with the Biomedical Advanced Research and Development Authority of the Department of Health and Human Services, for the development of a recombinant protective antigen anthrax vaccine.
The Nursing Program at the Akron Campus of Bryant & Stratton College has received initial accreditation from the Accreditation Commission for Education in Nursing (ACEN) for the maximum period of five years.
A University of Illinois at Chicago researcher will test whether brain stimulation combined with gait training can improve patients' ability to walk after a stroke, under a $1.5 million grant from the National Institute of Child Health and Human Development.
A sub-study of the Outcome Reduction with an Initial Glargine Intervention (ORIGIN) trial, designed to investigate the effect of insulin glargine and omega-3 fatty acids on atherosclerosis progression, has found that, compared to standard care, only insulin glargine (a long-acting insulin) had a "modest" statistically non-significant reducing effect on the primary outcome of rate of change in maximum carotid intima media thickness (CIMT) at 12 carotid sites.
Prometheus Research LLC has formed the Prometheus Solutions group to help customers develop data-driven solutions, including dashboards and reports. The group will draw on expertise developed by the company in its ten years of building custom biomedical data management applications.
› Verified 3 days ago
Entity Name | Singing River Gulfport |
---|---|
Entity Type | Part B Supplier - Hospital Department(s) |
Entity Identifiers | NPI Number: 1780312504 PECOS PAC ID: 5294154829 Enrollment ID: O20230106000462 |
News Archive
Emergent BioSolutions Inc. announced today that it has signed a contract, valued at up to $186.6 million, with the Biomedical Advanced Research and Development Authority of the Department of Health and Human Services, for the development of a recombinant protective antigen anthrax vaccine.
The Nursing Program at the Akron Campus of Bryant & Stratton College has received initial accreditation from the Accreditation Commission for Education in Nursing (ACEN) for the maximum period of five years.
A University of Illinois at Chicago researcher will test whether brain stimulation combined with gait training can improve patients' ability to walk after a stroke, under a $1.5 million grant from the National Institute of Child Health and Human Development.
A sub-study of the Outcome Reduction with an Initial Glargine Intervention (ORIGIN) trial, designed to investigate the effect of insulin glargine and omega-3 fatty acids on atherosclerosis progression, has found that, compared to standard care, only insulin glargine (a long-acting insulin) had a "modest" statistically non-significant reducing effect on the primary outcome of rate of change in maximum carotid intima media thickness (CIMT) at 12 carotid sites.
Prometheus Research LLC has formed the Prometheus Solutions group to help customers develop data-driven solutions, including dashboards and reports. The group will draw on expertise developed by the company in its ten years of building custom biomedical data management applications.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Jonathan White, CRNA 2101 Highway 90, Gautier, MS 39553-5340 Ph: (228) 497-7576 | Jonathan White, CRNA 2809 Denny Ave, Pascagoula, MS 39581-5301 Ph: (228) 809-5000 |
News Archive
Emergent BioSolutions Inc. announced today that it has signed a contract, valued at up to $186.6 million, with the Biomedical Advanced Research and Development Authority of the Department of Health and Human Services, for the development of a recombinant protective antigen anthrax vaccine.
The Nursing Program at the Akron Campus of Bryant & Stratton College has received initial accreditation from the Accreditation Commission for Education in Nursing (ACEN) for the maximum period of five years.
A University of Illinois at Chicago researcher will test whether brain stimulation combined with gait training can improve patients' ability to walk after a stroke, under a $1.5 million grant from the National Institute of Child Health and Human Development.
A sub-study of the Outcome Reduction with an Initial Glargine Intervention (ORIGIN) trial, designed to investigate the effect of insulin glargine and omega-3 fatty acids on atherosclerosis progression, has found that, compared to standard care, only insulin glargine (a long-acting insulin) had a "modest" statistically non-significant reducing effect on the primary outcome of rate of change in maximum carotid intima media thickness (CIMT) at 12 carotid sites.
Prometheus Research LLC has formed the Prometheus Solutions group to help customers develop data-driven solutions, including dashboards and reports. The group will draw on expertise developed by the company in its ten years of building custom biomedical data management applications.
› Verified 3 days ago
Amanda Graham Dobbins, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 2809 Denny Ave, Pascagoula, MS 39581 Phone: 228-806-4525 | |
Mr. Laird Miller, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2809 Denny Ave, Pascagoula, MS 39581 Phone: 228-809-5000 | |
Andrew J Zielinski, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2809 Denny Ave, Pascagoula, MS 39581 Phone: 228-809-5540 Fax: 228-809-1153 | |
Mr. Christopher Arlen Jones, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2809 Denny Ave, Pascagoula, MS 39581 Phone: 228-809-5531 Fax: 228-809-1153 | |
Mrs. Christine Cooper Bowman, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2809 Denny Ave, Pascagoula, MS 39581 Phone: 228-809-5000 | |
Robert Shotlander, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2809 Denny Ave, Pascagoula, MS 39581 Phone: 228-809-5000 |